Entheon Biomedical Provides Corporate Update on Studies and Clinical Trials

Entheon Biomedical Corp., a biotechnology company focused on developing psychedelic medicines to treat addiction, is pleased to provide an update on its operations and progress on its strategic initiatives.

Category Press Release
?>